Search

everythinglearnresearchcommunity

for

Search:↓

DORN1 receptor affects eATP-induced stomatal changes but not eADP in Arabidopsis thaliana.

Minoxidil boosts plasma renin activity, influenced by control plasma renin activity and changes in sympathetic tone.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Amlodipine impairs fertility in male rats by affecting sperm and testicular structure.

Two gene areas linked to male pattern baldness found, more research needed.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Potassium channel modulators mostly increase the activity of rat whisker mechanoreceptors.

The research found that androgens help control blood flow in the rat prostate through a specific binding site.

A specific genetic mutation may increase male pattern baldness risk, especially in Europeans.

NXC736 significantly reduced hair loss in mice with alopecia areata.

Different types of androgens bind differently to two receptors, AR1 and AR2, in Atlantic croaker's brain and ovarian tissues, suggesting these receptors may control different androgen actions in fish.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Minoxidil might partially activate estrogen receptors, affecting hair growth.

Blocking a protein called prostaglandin D2 might help treat hair loss.

Aire mutation reduces alopecia areata, while Notch4 mutation prevents it in mice.

4-aminopyridine speeds up and improves skin wound healing.

A new treatment using a DNA aptamer can promote hair growth by targeting a specific receptor.

Certain amino acids in 5AR1 and 5AR2 are crucial for binding and resistance to Finasteride.

Mutations in certain receptors can cause diseases and offer new treatment options.

ADT for prostate cancer may harm the heart, but GnRH antagonists might be safer.

Some men's prostate tissues have low enzyme levels due to genetic changes, possibly affecting treatment for prostate enlargement.

A specific gene change is linked to severe hair loss.

The study found that androgen receptors in skin cells mainly affect the focal adhesion pathway and control the caveolin-1 gene, with implications for new treatments for related diseases.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

Hair loss gene linked to prostate issues.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Minoxidil sulfate relaxes muscle by increasing potassium flow, making it a unique muscle relaxer.

Minoxidil can reduce functions related to androgen receptors.

Women with hair loss have more androgen receptors in certain hair follicles.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.